On 30 June 2024, the board of directors of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. received a resignation letter from Mr. Yao Fang (``Mr. Yao''). Mr. Yao resigned as a non-executive Director due to work reassignment, and ceased to be a member of the strategic committee of the Board (``Strategic Committee''). In accordance with the articles of association of the Company, the resignation of Mr. Yao shall become effective from 30 June 2024.

The company also announced that Mr. Wang Kexin has been appointed as a member of the Strategic Committee of the Board, with effect from 1 July 2024. Given Mr. Yao resigned as a non-executive Director and ceased to be a member of the Strategic Committee effective from 30 June 2024, the Board announces that Mr. Wang Kexin has been appointed as a member of the Strategic Committee with effect from 1 July 2024.